ResultsIQ

ResultsIQ › Latest results › Balaji Amines Limited

Balaji Amines Limited Q4 FY25 results press release summary

NSE: BALAMINES · BSE: 530999

Results press release of 29 May 2025, summarised by AI from the filing.

Management expects EBITDA and PAT margins to improve as volume uptake increases, with better utilization of expanded capacities supporting recovery in coming quarters.

Key takeaways

  1. Margin guidance Management expects EBITDA and PAT margins to improve as volume uptake increases, with better utilization of expanded capacities supporting recovery in coming quarters.
  2. Sequential improvement Q4 FY25 performance improved compared to the rest of the financial year, supported by favorable global macroeconomic conditions.
  3. Growth driver Steady pharmaceutical sector demand contributed to base volumes, while strategic capex initiatives including Electronic Grade DMC, Propylene Glycol Pharma Grade and Dimethyl Ether progressed as planned.
  4. Main risk Geopolitical tensions and tariff-related challenges may continue to impact growth across several sectors and have weighed on domestic demand.

Original filing on BSE

Balaji Amines Limited Q1 FY27 results

As filed: Revenue ₹456 cr (+27% year on year), EBITDA ₹116 cr (+111% year on year), PAT ₹78.1 cr (+111% year on year), EBITDA margin 25.4% (+1,000 bps).

The Q1 FY27 score, against the company's own trend, is for premium members.

Earlier results and the share price after them

  • Q4 FY26: Revenue ₹395 cr (+12% year on year), EBITDA ₹94.3 cr (+57% year on year), PAT ₹64.8 cr (+62% year on year), EBITDA margin 23.9% (+688 bps). Score 93 of 100, Above trend. Revenue, EBITDA and profit growth were well above the company's own trend. EBITDA margin rose 688 bps year on year. Revenue grew on the previous quarter, against its usual seasonal pattern. Share price after the results: +57.7% in 30 days (Nifty 500: +1.0%).
  • Q3 FY26: Revenue ₹331 cr (+6% year on year), EBITDA ₹56.7 cr (+23% year on year), PAT ₹30.8 cr (−1% year on year), EBITDA margin 17.1% (+241 bps). Score 65 of 100, In line with trend. Revenue growth was above the company's own trend; EBITDA growth was well above it; profit growth was in line with it. EBITDA margin rose 241 bps year on year. Profit fell 17% from last quarter. Share price after the results: −10.9% in 29 days (Nifty 500: +0.4%).
  • Q2 FY26: Revenue ₹341 cr (−2% year on year), EBITDA ₹60.0 cr (−2% year on year), PAT ₹37.0 cr (−10% year on year), EBITDA margin 17.6% (+2 bps). Score 48 of 100, In line with trend. Revenue and EBITDA growth were in line with the company's own trend; profit growth was below it. EBITDA margin was flat year on year. Revenue fell 5% from last quarter. Share price after the results: −17.5% in 30 days (Nifty 500: −0.8%).
  • Q1 FY26: Revenue ₹358 cr (−7% year on year), EBITDA ₹55.0 cr (−18% year on year), PAT ₹37.0 cr (−20% year on year), EBITDA margin 15.4% (−204 bps). Score 35 of 100, Below trend. Revenue, EBITDA and profit growth were below the company's own trend. EBITDA margin fell 204 bps year on year. Profit fell 7% from last quarter. Share price after the results: −12.8% in 30 days (Nifty 500: +0.2%).
  • Q4 FY25: Revenue ₹353 cr (−15% year on year), EBITDA ₹60.0 cr (−38% year on year), PAT ₹40.0 cr (−44% year on year), EBITDA margin 17.0% (−643 bps). Score 19 of 100, Below trend. Revenue, EBITDA and profit growth were well below the company's own trend. EBITDA margin fell 643 bps year on year. Share price after the results: +19.9% in 30 days (Nifty 500: +3.7%).
  • Q3 FY25: Revenue ₹313 cr (−18% year on year), EBITDA ₹46.0 cr (−39% year on year), PAT ₹31.0 cr (−45% year on year), EBITDA margin 14.7% (−489 bps). Score 19 of 100, Below trend. Revenue, EBITDA and profit growth were well below the company's own trend. EBITDA margin fell 489 bps year on year. Revenue fell 10% from last quarter.
  • Q2 FY25: Revenue ₹347 cr (−9% year on year), EBITDA ₹61.0 cr (+13% year on year), PAT ₹41.0 cr (+14% year on year), EBITDA margin 17.6% (+341 bps). Score 45 of 100, In line with trend. EBITDA margin rose 341 bps year on year. Not enough history for a trend yet: scored on growth alone. Revenue fell 10% from last quarter.

Past price moves after results do not indicate future moves. Not a recommendation.

Balaji Amines Limited earnings call, investor presentation and press release summaries

Figures from the company's filings with NSE and BSE. Not investment advice.